Results 271 to 280 of about 1,883,043 (318)

ERK autoinhibition mechanism informs a drug combination strategy. [PDF]

Protein Sci
Regev C, Jang H, Nussinov R.
europepmc   +1 more source

RK3, a G-Type LecRLK, Interacts with FLS2 and BAK1 to Promote flg22-Triggered Immunity. [PDF]

Biology (Basel)
Zhang L, Yuan Z, Yao L, Xiao H.
europepmc   +1 more source

Successful Re-challenge of zongertinib following erythema multiforme-like drug eruption in a patient with HER2-mutant non-small cell lung cancer. [PDF]

Respir Med Case Rep
Kawamura K, Kubota K, Ichikado K.
europepmc   +1 more source

Multi-Omics Analyses Elucidate the Venom Components of the Wasp <i>Vespa mandarinia</i>. [PDF]

Ecol Evol
Shi YC, Mo HF, Yu SH, Niu XY, Yang P.
europepmc   +1 more source

Statement of Retraction: WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling. [PDF]

Bioengineered
europepmc   +1 more source

Refractory nail lichen planus treated successfully with the Janus kinase 1 inhibitor abrocitinib: A case report. [PDF]

J Int Med Res
Wang L, Lei X, Li L, Cheng Q.
europepmc   +1 more source

Statement of Retraction: MiR-4739 inhibits the malignant behavior of esophageal squamous cell carcinoma cells via the homeobox C10/vascular endothelial growth factor A/phosphatidylinositol 3-kinase/AKT pathway. [PDF]

Bioengineered
europepmc   +1 more source